In this insightful narrative review, Nasrallah et al.[
1] explore a timely and emerging concept: the use of artificial intelligence (AI) to improve patient selection and outcome prediction for varicocelectomy, a procedure often surrounded by clinical ambiguity. The article delivers a clear and concise synthesis of early but promising applications of machine learning (ML) in the context of male infertility, highlighting the potential for AI to move us beyond traditional parameters like semen analysis and toward more clinically meaningful outcomes.
The authors succeed in illuminating how data-driven tools can support decision-making in an area long challenged by patient heterogeneity and unpredictable treatment efficacy. By reviewing models that focus on post-surgical reproductive trajectories—such as transitioning from in vitro fertilization to intrauterine insemination or spontaneous pregnancy—they underscore the relevance of AI for tailoring treatment to real-life goals rather than laboratory metrics.
For instance, Ory et al.[
2] developed an ML model that predicts clinically meaningful improvements in fertility post-varicocelectomy, focusing on transitions in assisted reproductive technology eligibility rather than solely on semen parameter changes. Further reinforcing the potential of AI, a pilot study by Kaya et al.[
3] employed various ML algorithms, including Extra Trees Classifier and XGBoost, to predict postoperative improvements in total motile sperm count. The study achieved an impressive area under the curve of 0.92, underscoring the efficacy of ML in forecasting varicocelectomy outcomes.
One of the most compelling contributions of this review is its balanced presentation. While advocating for AI's integration, it remains grounded in the current limitations: small sample sizes, lack of prospective validation, and the inherent opacity of black-box algorithms. These are valid concerns that will require methodological transparency and multi-institutional collaboration.
Contextually, this work builds on a growing body of literature that suggests AI may play a key role in redefining surgical indications—not just for varicocele, but across male reproductive surgery. Compared to earlier predictive tools, AI models offer the agility and nuance needed to capture nonlinear and complex biological relationships that have long eluded conventional statistics.
Future work should prioritize prospective validation, standardized outcome definitions, and ethical considerations regarding AI-driven recommendations. There is also room to expand AI use into diagnostic domains, image recognition, and patient counseling platforms, especially in low-resource settings where expertise may be limited. Overall, this review is an important step toward a more predictive and personalized era in andrology. As the clinical landscape evolves, AI will not replace surgeon judgment, but it may profoundly inform it.
2025 The Author(s). UroPrecision published by John Wiley & Sons Australia, Ltd on behalf of Higher Education Press.
PDF
(67KB)
